These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 11705940)

  • 1. DNA adenine methylase is essential for viability and plays a role in the pathogenesis of Yersinia pseudotuberculosis and Vibrio cholerae.
    Julio SM; Heithoff DM; Provenzano D; Klose KE; Sinsheimer RL; Low DA; Mahan MJ
    Infect Immun; 2001 Dec; 69(12):7610-5. PubMed ID: 11705940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with a DNA adenine methylase over-producing Yersinia pseudotuberculosis vaccine confers robust cross-protection against heterologous pathogenic serotypes.
    Kubicek-Sutherland JZ; Heithoff DM; Ersoy SC; Shimp WR; Mahan MJ
    Vaccine; 2014 Mar; 32(13):1451-9. PubMed ID: 24508035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LcrV synthesis is altered by DNA adenine methylase overproduction in Yersinia pseudotuberculosis and is required to confer immunity in vaccinated hosts.
    Badie G; Heithoff DM; Mahan MJ
    Infect Immun; 2004 Nov; 72(11):6707-10. PubMed ID: 15501808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA adenine methylase overproduction in Yersinia pseudotuberculosis alters YopE expression and secretion and host immune responses to infection.
    Julio SM; Heithoff DM; Sinsheimer RL; Low DA; Mahan MJ
    Infect Immun; 2002 Feb; 70(2):1006-9. PubMed ID: 11796641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral immunization with a dam mutant of Yersinia pseudotuberculosis protects against plague.
    Taylor VL; Titball RW; Oyston PCF
    Microbiology (Reading); 2005 Jun; 151(Pt 6):1919-1926. PubMed ID: 15941999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A putative DNA adenine methyltransferase is involved in Yersinia pseudotuberculosis pathogenicity.
    Pouillot F; Fayolle C; Carniel E
    Microbiology (Reading); 2007 Aug; 153(Pt 8):2426-2434. PubMed ID: 17660407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered Ca(2+) regulation of Yop secretion in Yersinia enterocolitica after DNA adenine methyltransferase overproduction is mediated by Clp-dependent degradation of LcrG.
    Fälker S; Schmidt MA; Heusipp G
    J Bacteriol; 2006 Oct; 188(20):7072-81. PubMed ID: 17015646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A protective epitope in type III effector YopE is a major CD8 T cell antigen during primary infection with Yersinia pseudotuberculosis.
    Zhang Y; Mena P; Romanov G; Lin JS; Smiley ST; Bliska JB
    Infect Immun; 2012 Jan; 80(1):206-14. PubMed ID: 22064714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YopE specific CD8+ T cells provide protection against systemic and mucosal Yersinia pseudotuberculosis infection.
    González-Juarbe N; Shen H; Bergman MA; Orihuela CJ; Dube PH
    PLoS One; 2017; 12(2):e0172314. PubMed ID: 28207901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salmonella DNA adenine methylase mutants confer cross-protective immunity.
    Heithoff DM; Enioutina EY; Daynes RA; Sinsheimer RL; Low DA; Mahan MJ
    Infect Immun; 2001 Nov; 69(11):6725-30. PubMed ID: 11598044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An essential role for DNA adenine methylation in bacterial virulence.
    Heithoff DM; Sinsheimer RL; Low DA; Mahan MJ
    Science; 1999 May; 284(5416):967-70. PubMed ID: 10320378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholera toxin-B (ctxB) antigen expressing Salmonella Typhimurium polyvalent vaccine exerts protective immune response against Vibrio cholerae infection.
    Vishwakarma V; Sahoo SS; Das S; Ray S; Hardt WD; Suar M
    Vaccine; 2015 Apr; 33(15):1880-9. PubMed ID: 25701672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral vaccination against pseudotuberculosis.
    Thornton EA; Smith GR
    Vaccine; 1996 Jul; 14(10):977-81. PubMed ID: 8873391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against Yersinia pseudotuberculosis infection conferred by a Lactococcus lactis mucosal delivery vector secreting LcrV.
    Daniel C; Sebbane F; Poiret S; Goudercourt D; Dewulf J; Mullet C; Simonet M; Pot B
    Vaccine; 2009 Feb; 27(8):1141-4. PubMed ID: 19135495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the phoPQ operon in the pathogenesis of the fully virulent CO92 strain of Yersinia pestis and the IP32953 strain of Yersinia pseudotuberculosis.
    Bozue J; Mou S; Moody KL; Cote CK; Trevino S; Fritz D; Worsham P
    Microb Pathog; 2011 Jun; 50(6):314-21. PubMed ID: 21320584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the structure and regulation of the udp gene of Vibrio cholerae, Yersinia pseudotuberculosis, Salmonella typhimurium, and Escherichia coli.
    Zolotukhina M; Ovcharova I; Eremina S; Errais Lopes L; Mironov AS
    Res Microbiol; 2003 Sep; 154(7):510-20. PubMed ID: 14499937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salmonella DNA adenine methylase mutants elicit protective immune responses to homologous and heterologous serovars in chickens.
    Dueger EL; House JK; Heithoff DM; Mahan MJ
    Infect Immun; 2001 Dec; 69(12):7950-4. PubMed ID: 11705984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of the recombinant plasmid carrying the genes of cholera prophages CTX and RS1 on the expression of virulence and immunogenicity genes in the cholera pathogen].
    Smirnov NI; Zadnova SP; Toporkov AV
    Mol Gen Mikrobiol Virusol; 2005; (3):3-8. PubMed ID: 16173391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral inoculation with Type III secretion mutants of Yersinia pseudotuberculosis provides protection from oral, intraperitoneal, or intranasal challenge with virulent Yersinia.
    Balada-Llasat JM; Panilaitis B; Kaplan D; Mecsas J
    Vaccine; 2007 Feb; 25(8):1526-33. PubMed ID: 17194509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Yersinia pseudotuberculosis outer proteins (Yops) on interleukin-12, tumor necrosis factor alpha and nitric oxide production by peritoneal macrophages.
    Monnazzi LG; Carlos IZ; de Medeiros BM
    Immunol Lett; 2004 Jun; 94(1-2):91-8. PubMed ID: 15234540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.